Medicare Enrolled
Dr. Rikki Racela, MD
Neurology · Englewood, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Racela from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Racela?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Racela
Dr. Rikki Racela is a neurology specialist in Englewood, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Racela performed 2,343 Medicare services across 1,477 unique beneficiaries.
Between the years covered by Open Payments, Dr. Racela received a total of $123,515 from 106 pharmaceutical and/or device companies across 2142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Racela is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in NJ
$123,515 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,343
Medicare services
Top 17% in NJ for neurology
1,477
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~123 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,044 | $68 | $160 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
243 | $74 | $165 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
226 | $150 | $445 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
213 | $31 | $130 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
170 | $178 | $485 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
101 | $47 | $190 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
63 | $90 | $315 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
48 | $70 | $220 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
40 | $179 | $690 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
36 | $113 | $300 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
22 | $116 | $520 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
18 | $19 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $97 | $240 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
16 | $148 | $820 |
| New patient office visit, complex (60-74 min) | 16 | $178 | $460 |
| Emergency department visit, low level of medical decision making An emergency department visit for a patient requiring a low level of medical decision making. |
16 | $58 | $135 |
| Lumbar puncture for diagnostic test A procedure to remove cerebrospinal fluid from the lower back for diagnostic testing. |
14 | $54 | $260 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $138 | $365 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
13 | $160 | $685 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $46 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$123,515
Total received (2018-2024)
Avg $17,645/year across 7 years
Top 3% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
106
Companies
2,142
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57,357 (46.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$45,680 (37.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,478 (16.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,238
2023
$24,555
2022
$25,162
2021
$26,342
2020
$24,723
2019
$5,486
2018
$3,009
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$4,795
Teva Pharmaceuticals USA, Inc.
$1,086
EMD Serono, Inc.
$757
SK Life Science, Inc.
$685
Eisai Inc.
$536
UCB, Inc.
$412
ACADIA Pharmaceuticals Inc
$388
Lundbeck LLC
$378
Avadel CNS Pharmaceuticals, LLC
$367
Biogen, Inc.
$327
ARGENX US, INC.
$314
Alexion Pharmaceuticals, Inc.
$302
Lilly USA, LLC
$278
TG Therapeutics, Inc.
$272
GENZYME CORPORATION
$260
Ambu A/S
$250
PFIZER INC.
$237
Otsuka America Pharmaceutical, Inc.
$229
Amgen Inc.
$214
Neurocrine Biosciences, Inc.
$214
Novartis Pharmaceuticals Corporation
$209
Genentech USA, Inc.
$171
AstraZeneca Pharmaceuticals LP
$164
JAZZ PHARMACEUTICALS INC.
$153
HARMONY BIOSCIENCES LLC
$146
MDD US Operations, LLC
$135
Celgene Corporation
$123
Axsome Therapeutics, Inc.
$120
E.R. Squibb & Sons, L.L.C.
$117
Aucta Pharmaceuticals, Inc.
$101
Kyowa Kirin, Inc.
$78
CSL Behring
$73
Azurity Pharmaceuticals, Inc.
$50
Neurelis, Inc.
$48
SCILEX PHARMACEUTICALS INC.
$32
Alnylam Pharmaceuticals Inc.
$31
Harmony Biosciences Llc
$29
Neuronetics, Inc.
$26
CATALYST PHARMACEUTICALS, INC.
$24
GE HEALTHCARE
$20
Inspire Medical Systems, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$17
Life Molecular Imaging Ltd
$17
BANNER LIFE SCIENCES, LLC
$16
Acorda Therapeutics, Inc
$16
Top 3 companies account for 46.6% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$21,350
ABBVIE INC.
$17,468
Allergan, Inc.
$14,220
SK Life Science, Inc.
$9,826
AbbVie Inc.
$7,332
EMD Serono, Inc.
$5,705
Teva Pharmaceuticals USA, Inc.
$5,390
E.R. Squibb & Sons, L.L.C.
$3,561
Biogen, Inc.
$3,470
Novartis Pharmaceuticals Corporation
$3,255
Neurocrine BioSciences, Inc.
$2,800
ACADIA Pharmaceuticals Inc
$1,979
Celgene Corporation
$1,840
Sarepta Therapeutics, Inc.
$1,500
Lundbeck LLC
$1,378
Genentech USA, Inc.
$1,220
Lilly USA, LLC
$996
Allergan Inc.
$956
GENZYME CORPORATION
$890
Alexion Pharmaceuticals, Inc.
$877
Biohaven Pharmaceuticals, Inc.
$833
Amgen Inc.
$826
JAZZ PHARMACEUTICALS INC.
$804
CSL Behring
$717
Otsuka America Pharmaceutical, Inc.
$686
Abbott Laboratories
$681
Biohaven Pharmaceutical Holding Company Ltd.
$664
Eisai Inc.
$642
UCB, Inc.
$629
Horizon Therapeutics plc
$586
Janssen Pharmaceuticals, Inc
$522
PFIZER INC.
$504
AstraZeneca Pharmaceuticals LP
$502
ARGENX US, INC.
$498
Medtronic Vascular, Inc.
$419
Harmony Biosciences LLC
$405
LivaNova USA, Inc.
$400
Avadel CNS Pharmaceuticals, LLC
$392
Boston Scientific Corporation
$378
HARMONY BIOSCIENCES LLC
$305
Acorda Therapeutics, Inc
$303
Neurelis, Inc.
$301
Medtronic, Inc.
$300
Kyowa Kirin, Inc.
$299
MDD US Operations, LLC
$296
TG Therapeutics, Inc.
$272
W. L. Gore & Associates, Inc.
$271
Alnylam Pharmaceuticals Inc.
$258
Ambu A/S
$250
TG THERAPEUTICS, INC.
$243
Upsher-Smith Laboratories LLC
$241
Greenwich Biosciences, Inc.
$212
Adamas Pharmaceuticals, Inc.
$175
Axsome Therapeutics, Inc.
$167
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$135
Penumbra, Inc.
$127
Banner Life Sciences, LLC
$125
Medtronic USA, Inc.
$123
AbbVie, Inc.
$123
AQUESTIVE THERAPEUTICS, INC.
$113
Grifols USA, LLC
$112
Aucta Pharmaceuticals, Inc.
$101
IMPEL PHARMACEUTICALS INC.
$84
Azurity Pharmaceuticals, Inc.
$84
Supernus Pharmaceuticals, Inc.
$75
Sunovion Pharmaceuticals Inc.
$73
Aries Pharmaceuticals, Inc.
$72
Impax Laboratories, Inc.
$72
Arbor Pharmaceuticals, Inc.
$69
Avanir Pharmaceuticals, Inc.
$66
Jazz Pharmaceuticals Inc.
$54
GE HEALTHCARE
$52
Neuronetics, Inc.
$45
Currax Pharmaceuticals LLC
$44
Mallinckrodt LLC
$44
Amneal Pharmaceuticals LLC
$43
CATALYST PHARMACEUTICALS, INC.
$43
Vertical Pharmaceuticals, LLC
$42
Octapharma USA, Inc.
$40
Bausch Health US, LLC
$38
SCILEX PHARMACEUTICALS INC.
$32
BANNER LIFE SCIENCES, LLC
$31
Almatica Pharma LLC
$30
Harmony Biosciences Llc
$29
ASSERTIO THERAPEUTICS, Inc.
$28
Mallinckrodt Hospital Products Inc.
$28
EISAI INC.
$27
Assertio Therapeutics, Inc.
$25
Validus Pharmaceuticals LLC
$25
Inspire Medical Systems, Inc.
$20
Strongbridge US INC.
$18
Mallinckrodt Enterprises LLC
$18
Ipsen Biopharmaceuticals, Inc
$17
Life Molecular Imaging Ltd
$17
Merck Sharp & Dohme LLC
$16
ARBOR PHARMACEUTICALS, INC.
$16
Corium, LLC
$16
Avion Pharmaceuticals
$16
Scilex Pharmaceuticals Inc.
$15
Zyla Life Sciences, Inc.
$15
Aprecia Pharmaceuticals, LLC
$15
UPSHER-SMITH LABORATORIES LLC
$15
Mitsubishi Tanabe Pharma America, Inc.
$14
PORTOLA PHARMACEUTICALS, INC.
$14
Tris Pharma Inc
$14
Shire North American Group Inc
$12
Top 3 companies account for 42.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · ARES · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Amplia MRI · Apokyn · Artemis · Austedo XR · Azstarys · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · CORNERSTONE · Cambia · Cenobamate · DAR · DAYBUE · DIAMONDBACK CORONARY · DUOPA · Dhivy · Duopa · Dyanavel XR · Dysport · ELEVIEW · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Eprontia · Equetro · FARXIGA · FIRDAPSE · Fycompa · GENERAL - THERAPIES · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · Gocovri · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MEROCEL · MIDAS REX · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NEURACEQ · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neuromodulation Dspsbls and Accs · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · Ponvory · QALSODY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RED 72 · REXULTI · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SPRAVATO · SPRIX · STRAIGHTSHOT · SUNOSI · SYMPAZAN · Soliris · Spritam · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · Wakix · XADAGO · XCOPRI · XYREM · XYWAV · Xyrem · ZEPOSIA · ZINBRYTA · ZOLGENSMA · ZTLido · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (46%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in NJ.
Geographic Context
Neurologists within 10 mi
1,271
Per 100K population
133.1
County median income
$123,715
Nearest hospital
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Racela is a mixed practice specialist, with above-average Medicare volume (top 17% in NJ), with speaking/promotional industry engagement in the top 3% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Racela experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Racela performed 1,044 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Racela receive payments from pharmaceutical companies?
Yes. Dr. Racela received a total of $123,515 from 106 companies across 2,142 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Racela's costs compare to other neurologists in Englewood?
Dr. Racela's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Racela) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Englewood
Browse neurologists in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology